Diagnostic and therapeutic value of intracellular biomarker testing in chronic pain

Aim: Micronutrient and metabolic compound supplementation as a method of treating chronic pain is not well understood. Case: A 58 year-old woman presented with refractory painful neuropathy. She did not respond to conservative treatment and was seeking spinal cord stimulator implantation. She underwent a biomarker panel that revealed low intracellular levels of multiple compounds. As she supplemented her deficiencies, her symptoms fully resolved, and the implant was no longer indicated. Discussion: Micronutrient and metabolic compound testing could potentially expand non-invasive treatment options for patients with refractory chronic pain. Caution should be exercised given limited regulatory oversight in the supplement industry and actively ongoing nutritional research. Conclusion: Biomarker testing panels may be a useful adjunct in the management of refractory neuropathic pain.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

Pain management - 14(2024), 1 vom: 26. Jan., Seite 21-27

Sprache:

Englisch

Beteiligte Personen:

Ye, Alice L [VerfasserIn]
Sudek, Emily W [VerfasserIn]
Magdaleno, Daniela [VerfasserIn]
Roldan, Carlos J [VerfasserIn]

Links:

Volltext

Themen:

Case Reports
Chronic pain
Journal Article
Metabolic compounds
Micronutrients
Neuropathic pain
Peripheral neuropathy

Anmerkungen:

Date Completed 26.01.2024

Date Revised 26.01.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.2217/pmt-2023-0080

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM366838938